Prostate stromal cells express biologically relevant levels of FGF2, and therefore the increase in FGF2 in the bone microenvironment may promote prostate cancer cell growth by providing a prostate-like environment (Kwabi-Addo et al. 2004, Pecqueux et al. 2018). This evidence concerns the gene FGF2 and prostate cancer.